Views: 0 Author: Shanghai Marya R&D Team Publish Time: 2026-10-15 Origin: Site
An ISO 5 cleanroom provides a highly controlled environment for critical pharmaceutical processes, such as aseptic filling and sterile component handling. However, not all manufacturing areas require ISO 5 classification. The appropriate cleanliness level depends on contamination risks, production processes, and GMP requirements.
This guide explains when ISO 5 is needed, how it compares with other cleanroom classes, and the key design requirements.
Table of Contents
An ISO 5 cleanroom is a controlled environment classified according to airborne particle concentration under ISO 14644-1.
It is designed to maintain extremely low levels of airborne particles through effective filtration, airflow management, and contamination control.
According to ISO 14644-1:2015, cleanroom classification is based on the concentration of airborne particles at specified sizes.
Particle Size | Maximum Permitted Concentration |
|---|---|
≥0.1 µm | 100,000 particles/m³ |
≥0.2 µm | 23,700 particles/m³ |
≥0.3 µm | 10,200 particles/m³ |
≥0.5 µm | 3,520 particles/m³ |
≥1.0 µm | 832 particles/m³ |
These limits define airborne particle cleanliness rather than the complete requirements for pharmaceutical sterility assurance.
An ISO 5 classification does not automatically guarantee GMP compliance. Pharmaceutical manufacturers must also consider microbial contamination, environmental monitoring, aseptic processing procedures, and equipment qualification.
ISO 5 conditions are typically required when manufacturing operations involve exposed sterile products or components that must be protected from airborne contamination.
The most common applications include aseptic pharmaceutical filling, sterile component handling, and certain biotechnology manufacturing processes.
Aseptic filling is one of the primary applications of ISO 5 environments.
During filling, sterilized products, containers, and closures may be exposed to the surrounding environment. Strict contamination control is necessary to minimize the risk of microbial contamination.
Typical applications include:
Sterile vial filling and sealing
Ampoule filling operations
Prefilled syringe filling
Sterile liquid pharmaceutical packaging
Aseptic component transfer
The FDA Guidance for Sterile Drug Products Produced by Aseptic Processing identifies ISO 5 conditions as appropriate for critical areas where sterile products and components are exposed.
For pharmaceutical manufacturers planning new production facilities, integrating suitable cleanroom environments with a Vial Filling Sealing Line helps support contamination control throughout the filling process.
ISO 5 conditions may also be necessary when sterilized components are exposed during manufacturing or assembly.
Examples include sterile stoppers, open vials, product-contact components, and equipment parts used during aseptic processing.
The required classification depends on whether components are exposed directly or protected within a validated closed system or barrier.
For example, an appropriately designed isolator can provide localized critical environmental conditions without requiring the entire surrounding room to meet ISO 5 standards.
Biotechnology processes often involve contamination-sensitive materials, particularly during sterile drug product manufacturing.
Some operations requiring critical environmental protection include:
Aseptic preparation of sterile biological products
Open sterile product transfers
Sterile filling of biotechnology products
Handling of exposed sterile processing components
However, not all biotechnology production stages require ISO 5 conditions.
Closed processing systems and non-critical manufacturing stages may use different environmental classifications based on contamination risk assessment.
Certain sterile compounding operations also require ISO Class 5 primary engineering controls under applicable regulatory standards.
These may include biological safety cabinets, laminar airflow workbenches, or compounding aseptic isolators.
However, sterile compounding facilities must follow their applicable requirements, which may differ from industrial pharmaceutical manufacturing regulations.
ISO 5, ISO 7, and ISO 8 represent different airborne particle cleanliness levels under ISO 14644-1.
A lower ISO class number indicates a cleaner environment with fewer permitted airborne particles.
Classification | Maximum Particles ≥0.5 µm/m³ | Typical Applications |
|---|---|---|
ISO 5 | 3,520 | Critical aseptic processing zones |
ISO 7 | 352,000 | Controlled processing and supporting cleanrooms |
ISO 8 | 3,520,000 | Lower-risk controlled manufacturing areas |
ISO 7 or ISO 8 environments may be suitable for supporting pharmaceutical operations when justified by process requirements and contamination risk assessments.
For example, pharmaceutical facilities may have different cleanliness zones for:
Material preparation and equipment staging
Component washing and preparation
Controlled manufacturing operations
Critical aseptic filling processes
Instead of classifying an entire facility as ISO 5, manufacturers can establish localized critical processing zones supported by appropriate surrounding environments.
This approach helps balance contamination control, operational efficiency, and facility construction costs.
However, environmental classification must always comply with applicable GMP requirements.
ISO Class 5 and EU GMP Grade A are closely related but are not identical regulatory concepts.
ISO 5 defines airborne particle cleanliness, while GMP Grade A includes additional contamination control requirements for critical pharmaceutical processing.
According to EU GMP Annex 1 – Manufacture of Sterile Medicinal Products, Grade A environments are used for high-risk operations such as aseptic filling and the handling of exposed sterile products.
GMP Grade A requirements extend beyond particle classification and include:
Microbiological contamination control
Appropriate airflow protection
Environmental monitoring
Personnel and material handling procedures
Contamination control strategies
Qualification and ongoing performance verification
In conventional aseptic manufacturing arrangements, Grade A critical zones are generally supported by Grade B background environments.
However, isolator technology can allow different surrounding cleanroom classifications when justified by risk assessment and regulatory requirements.
It is important to recognize that Grade B should not be automatically equated with ISO 7 under all operating conditions.
Manufacturers must evaluate the complete applicable GMP requirements rather than relying on airborne particle limits alone.
Designing an ISO 5 cleanroom requires careful coordination of filtration, airflow, room layout, pressure control, personnel movement, and environmental monitoring.
High-efficiency particulate air filtration is essential for maintaining low airborne particle concentrations.
For critical pharmaceutical applications, unidirectional airflow is commonly used to protect exposed sterile products and components from contamination.
Important design considerations include:
HEPA filter integrity and performance
Airflow direction and uniformity
Protection of critical processing areas
Equipment placement and airflow obstruction
Airflow visualization and qualification testing
Airflow visualization studies are particularly important because particle classification alone cannot demonstrate that critical operations are adequately protected.
Air change rates should be determined according to the facility design, contamination risks, and operating conditions.
ISO 14644-1 does not prescribe a universal air change rate for all ISO 5 cleanrooms.
The appropriate airflow volume depends on room configuration, process equipment, particle generation, and whether the critical environment is a full cleanroom or a localized clean zone.
Pressure differentials must also support the contamination control strategy.
Positive-pressure arrangements are commonly used to protect products from external contamination, while certain containment applications may require alternative pressure configurations.
Personnel and materials can introduce contamination into controlled environments.
Cleanroom layouts should therefore include suitable arrangements for:
Personnel gowning and entry
Material transfer
Equipment movement
Separation of clean and potentially contaminated flows
Controlled access to critical processing areas
A properly designed personnel and material flow reduces unnecessary movement and supports consistent cleanroom operation.
For aseptic pharmaceutical manufacturing, environmental monitoring includes both non-viable airborne particles and viable microbial contamination.
Monitoring programs should establish appropriate sampling locations, frequencies, alert and action limits, and investigation procedures.
These activities should be integrated into the facility's contamination control strategy.
Manufacturers planning new facilities can explore our Pharmaceutical Cleanroom Solutions, which integrate cleanroom design with pharmaceutical processing requirements.
Cleanroom qualification provides documented evidence that the facility and environmental control systems perform as intended.
ISO classification is an important part of qualification but does not replace complete pharmaceutical GMP requirements.
Qualification Activity | Main Purpose |
|---|---|
Design Qualification (DQ) | Verify the proposed design meets user and regulatory requirements |
Installation Qualification (IQ) | Confirm systems are installed according to approved specifications |
Operational Qualification (OQ) | Verify environmental control systems operate correctly |
Performance Qualification (PQ) | Demonstrate performance under representative operating conditions |
Cleanroom Classification | Confirm compliance with airborne particle limits |
Airflow Visualization | Evaluate airflow patterns and protection of critical areas |
HEPA Filter Integrity Testing | Verify installed filter integrity |
Environmental Monitoring | Evaluate ongoing particulate and microbiological control |
Qualification and requalification should follow applicable GMP requirements, approved protocols, and documented risk assessments.
For sterile manufacturing facilities, cleanroom qualification must also be coordinated with HVAC systems, process equipment, and the overall contamination control strategy.
Choosing the correct cleanroom classification begins with understanding the manufacturing process and its contamination risks.
Manufacturers should evaluate the following factors:
Determine whether the product must remain sterile and whether it is exposed during manufacturing.
Identify which operations involve open handling, aseptic connections, filling, or other contamination-sensitive activities.
Review relevant ISO standards, GMP requirements, and industry-specific guidance.
Determine whether the process requires a full classified cleanroom, localized unidirectional airflow, or a barrier system such as an isolator.
Establish appropriate qualification activities and environmental monitoring procedures to verify and maintain cleanroom performance.
A well-designed pharmaceutical facility may combine ISO 5 critical processing zones with supporting environments of different cleanliness levels.
The objective is to provide the necessary contamination control without unnecessarily increasing facility complexity or operating costs.
Both conventional cleanroom arrangements and isolators can provide suitable environmental protection for critical pharmaceutical operations.
However, they use different approaches to contamination control.
Factor | Conventional Critical Cleanroom Zone | Isolator System |
|---|---|---|
Contamination Protection | Controlled airflow and operating procedures | Physical separation from the surrounding environment |
Operator Interaction | More direct interaction with the critical zone | Reduced direct access during operation |
Background Classification | Typically requires a highly controlled surrounding area | May allow different backgrounds depending on design and GMP requirements |
Operational Flexibility | Depends on equipment and cleanroom configuration | Depends on isolator design and transfer systems |
Qualification | Cleanroom and process qualification | Isolator, decontamination, integrity, and process qualification |
Isolators can reduce direct operator interaction with critical processing zones, making them valuable for certain aseptic pharmaceutical applications.
However, isolator selection must consider decontamination procedures, material transfer, glove integrity, process compatibility, and maintenance requirements.
For new pharmaceutical production facilities, integrating a Sterile Isolator System with filling equipment may help improve contamination control and operational efficiency.
Designing an ISO 5 pharmaceutical cleanroom requires careful integration of environmental controls, process equipment, and qualification requirements.
At Marya, we provide pharmaceutical cleanroom engineering and integrated production solutions for manufacturers planning new facilities or upgrading existing operations.
Our services can include:
Pharmaceutical cleanroom layout planning
HVAC and environmental control system integration
Cleanroom equipment and component selection
Pharmaceutical production equipment integration
Installation and commissioning support
Cleanroom qualification assistance
We also offer Turnkey Cleanroom Project Solutions tailored to different pharmaceutical manufacturing requirements.
By considering facility design and production equipment together, manufacturers can develop cleanroom environments that support contamination control, operational efficiency, and future production needs.
Planning a new pharmaceutical cleanroom or upgrading an existing aseptic production facility?
Contact Marya to discuss your cleanroom classification, facility layout, equipment integration, and project requirements.
No. ISO 5 conditions are primarily associated with critical aseptic processing operations involving exposed sterile products or components. Other pharmaceutical manufacturing stages may require different classifications depending on contamination risks and GMP requirements.
Under ISO 14644-1, ISO 5 permits a maximum of 3,520 airborne particles per cubic meter at particle sizes of 0.5 µm and larger.
Not exactly. ISO 5 defines airborne particle cleanliness, while GMP Grade A includes additional requirements for microbiological contamination control, airflow protection, environmental monitoring, and sterile manufacturing practices.
Conventional Grade A aseptic processing areas generally require a Grade B background. However, isolators may allow different surrounding classifications when supported by appropriate risk assessments and GMP requirements.
ISO 14644-1 does not specify a single mandatory air change rate for ISO 5 cleanrooms. Required airflow depends on the cleanroom design, equipment configuration, contamination sources, and qualification results.
An appropriately designed isolator can provide a localized critical processing environment without requiring the entire surrounding room to be ISO 5. However, the critical zone and surrounding environment must meet applicable GMP requirements.
Qualification intervals depend on regulatory requirements and risk assessments. Under EU GMP Annex 1, the maximum routine requalification interval for Grade A and B cleanrooms is six months, with additional qualification potentially required after significant modifications.
An ISO 5 cleanroom is essential for critical pharmaceutical operations where exposed sterile products or components require strict airborne contamination control.
However, ISO 5 classification alone does not guarantee GMP compliance. Manufacturers must also consider microbial contamination risks, airflow protection, facility design, environmental monitoring, and qualification requirements.
Selecting the appropriate cleanroom classification and integrating contamination control into the manufacturing process helps ensure reliable pharmaceutical production and regulatory compliance.
